These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 22262155

  • 1. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
    Borel AL, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP.
    Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
    [Abstract] [Full Text] [Related]

  • 2. Improvement in insulin sensitivity following a 1-year lifestyle intervention program in viscerally obese men: contribution of abdominal adiposity.
    Borel AL, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP.
    Metabolism; 2012 Feb; 61(2):262-72. PubMed ID: 21864868
    [Abstract] [Full Text] [Related]

  • 3. Normalization of visceral adiposity is required to normalize plasma apolipoprotein B levels in response to a healthy eating/physical activity lifestyle modification program in viscerally obese men.
    Pelletier-Beaumont E, Arsenault BJ, Alméras N, Bergeron J, Tremblay A, Poirier P, Després JP.
    Atherosclerosis; 2012 Apr; 221(2):577-82. PubMed ID: 22321874
    [Abstract] [Full Text] [Related]

  • 4. Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss.
    Borel AL, Nazare JA, Baillot A, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP.
    Am J Physiol Endocrinol Metab; 2017 Apr 01; 312(4):E273-E281. PubMed ID: 28028035
    [Abstract] [Full Text] [Related]

  • 5. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
    Després JP, Ross R, Boka G, Alméras N, Lemieux I, ADAGIO-Lipids Investigators.
    Arterioscler Thromb Vasc Biol; 2009 Mar 01; 29(3):416-23. PubMed ID: 19112166
    [Abstract] [Full Text] [Related]

  • 6. Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity.
    Borel AL, Leblanc X, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP, Series F.
    Thorax; 2012 Aug 01; 67(8):735-41. PubMed ID: 22396182
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure.
    Onat A, Ayhan E, Hergenç G, Can G, Barlan MM.
    Metabolism; 2009 Jul 01; 58(7):963-70. PubMed ID: 19411085
    [Abstract] [Full Text] [Related]

  • 15. Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women.
    Rhéaume C, Arsenault BJ, Dumas MP, Pérusse L, Tremblay A, Bouchard C, Poirier P, Després JP.
    J Clin Endocrinol Metab; 2011 May 01; 96(5):1462-8. PubMed ID: 21325457
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.